MedPath

Safety and effectiveness assessment of injectable suspension of Inshape x Radiance plus for the treatment of the back of hand wrinkles

Phase 1
Recruiting
Conditions
The back of hand wrinkles.
Changes in skin texture
R23.4
Registration Number
IRCT20150101020514N31
Lead Sponsor
ano Darou Pajouhan Pardis Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

Age over 30 years
Moderate to very severe degree of hand wrinkles based on MHGS criteria
Agree to use safe methods of contraception.
Signing an informed consent form and agreed to follow up.

Exclusion Criteria

History of type 1 allergic reactions or anaphylaxis reaction
Pregnant or lactating or planning to become pregnant in the near future while studying
Allergy or sensitivity to lidocaine
Use of antiplatelet drugs during 72 hours before treatment and anticoagulant drugs during 2 weeks before or during treatment.
Any abnormality or history of surgery on the back of hand

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of subjects with improvement in back of hand wrinkles. Timepoint: 30 days after intervention. Method of measurement: Merz Hand Grading Scale (MHGS).
Secondary Outcome Measures
NameTimeMethod
Thickness and density of dermis. Timepoint: Before intervention and 6 months later. Method of measurement: Skin ultrasound.;Changes in the intensity of hand wrinkles. Timepoint: Before intervention and 6 months later. Method of measurement: Based on the GAIS (Global Aesthetic Improvement Scale).
© Copyright 2025. All Rights Reserved by MedPath